- Category rank
- #7 (tied) of 13 in Imaging
- Confidence
- Medium (60%)
- Last reviewed
- October 17, 2026
Represent CephX and think this score is inaccurate? Request a score review · Score changelog
| Criterion | Weight | Score |
|---|---|---|
Regulatory evidence FDA 510(k) clearances for CEPHX 2D cephalometric analysis (K231396, 2024) and CEPHX3D (K252538, 2026). | 30% | 7.5 |
Detection scope Cephalometric tracing and analysis, CBCT segmentation of teeth, bone, airway and nerves; ortho-focused. | 20% | 7.5 |
Imaging & PMS integrations Integrated into DEXIS DTX Studio Clinic and Greyfinch; 100+ lab, DSO, PMS and imaging partners. | 20% | 8.0 |
Chairside patient communication Diagnostic reports and predictive analyses; less chairside-education focus. | 15% | 7.0 |
Scale & support 18.5K registered clinicians and practices; 1.4M images processed in 80+ countries. | 15% | 8.0 |
Weighted result 7.6. Last reviewed Oct 17, 2026. How we score · Request a score review